Virtual Reality Application in Chemotherapy

NCT ID: NCT03707210

Last Updated: 2021-05-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

77 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-10-11

Study Completion Date

2019-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present study wants to design a training program for chemotherapy with using VR. Then the investigators design a protocol to compare the training effects in the VR program and ISO document.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

As technology advances, mobile devices have gradually turned into wearable devices. Furthermore, virtual reality (VR), augmented reality (AR), and mixed reality (MR) are being increasingly applied in medical fields such as medical education and training, surgical simulation, neurological rehabilitation, psychotherapy, and telemedicine. Research results demonstrate the ability of VR, AR, and MR to ameliorate the inconveniences that are often associated with traditional medical care, reduce incidents of medical malpractice caused by unskilled operations, and reduce the cost of medical education and training. What is more, the application of these technologies has enhanced the effectiveness of medical education and training, raised the level of diagnosis and treatment, improved the doctor-patient relationship, and boosted the efficiency of medical execution. The present study wants to design a training program for chemotherapy with using VR. Then the investigators design a protocol to compare the training effects in VR program and ISO document.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chemotherapy Training

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

intervention: VR training; control group: ISO document
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

The experimental group uses the VR program to training chemotherapy skill. Use VR software to make a training education program.

Group Type EXPERIMENTAL

VR training program

Intervention Type BEHAVIORAL

Use VR software to make a training education program.

usual care

Chemotherapy training as usual care (for training chemotherapy skill).

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

VR training program

Use VR software to make a training education program.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. The staffs who require to implement chemotherapy skill in the hospital.
2. Age over 20 years.

Exclusion Criteria

1\. Refuse to join the study.
Minimum Eligible Age

20 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Taipei Medical University WanFang Hospital

OTHER

Sponsor Role collaborator

Taipei Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tsai-Wei Huang

Role: PRINCIPAL_INVESTIGATOR

Taipei Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Taipei Medical University

Taipei County, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

References

Explore related publications, articles, or registry entries linked to this study.

Chan HY, Chang HC, Huang TW. Virtual reality teaching in chemotherapy administration: Randomised controlled trial. J Clin Nurs. 2021 Jul;30(13-14):1874-1883. doi: 10.1111/jocn.15701. Epub 2021 Feb 18.

Reference Type DERIVED
PMID: 33555626 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

N201902009

Identifier Type: REGISTRY

Identifier Source: secondary_id

N201902009

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.